In spring 2017, Innovatix conducted a survey of its home infusion pharmacy members to better understand the consequences of the infusion policies in the 21st Century Cures Act from a financial, patient access, and job loss perspective. Innovatix members reported the law will have substantial consequences for infusion beneficiaries and their businesses.
Please see the survey analysis below:
Questions or comments regarding the survey and its results? Please contact Shara Siegel, Director of Government Affairs, at firstname.lastname@example.org.